| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
87,289 |
59,124 |
$5.05M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,774 |
7,615 |
$326K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,022 |
3,956 |
$314K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,933 |
3,922 |
$306K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
28,928 |
24,928 |
$258K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,593 |
2,584 |
$218K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,032 |
2,613 |
$217K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,858 |
4,257 |
$164K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,265 |
3,728 |
$142K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,846 |
5,048 |
$139K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,276 |
1,272 |
$108K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,190 |
1,188 |
$101K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,136 |
1,130 |
$95K |
| 69210 |
|
1,340 |
1,313 |
$42K |
| 90677 |
|
164 |
163 |
$38K |
| 99050 |
|
2,573 |
2,415 |
$31K |
| 99188 |
|
2,958 |
2,946 |
$30K |
| 12001 |
|
279 |
279 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
429 |
375 |
$17K |
| 99381 |
|
182 |
181 |
$14K |
| 90461 |
|
435 |
430 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
5,925 |
5,672 |
$8K |
| 83655 |
|
739 |
730 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
199 |
195 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
234 |
220 |
$3K |
| D1206 |
Topical application of fluoride varnish |
95 |
95 |
$3K |
| 88738 |
|
693 |
686 |
$3K |
| 81002 |
|
1,152 |
1,028 |
$3K |
| 90656 |
|
155 |
154 |
$2K |
| 87634 |
|
65 |
63 |
$2K |
| 90660 |
|
94 |
94 |
$1K |
| 36410 |
|
97 |
97 |
$1K |
| 0001A |
|
29 |
29 |
$1K |
| 81000 |
|
349 |
300 |
$1K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
16 |
16 |
$1K |
| 0002A |
|
26 |
26 |
$1K |
| 99441 |
|
37 |
35 |
$462.89 |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
123 |
121 |
$367.18 |
| 81003 |
|
115 |
106 |
$231.79 |
| 86580 |
|
12 |
12 |
$82.46 |
| 90715 |
|
12 |
12 |
$78.14 |
| 90698 |
|
90 |
87 |
$17.85 |
| 90670 |
|
16 |
16 |
$17.85 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
86 |
79 |
$10.94 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
27 |
26 |
$10.05 |
| 90619 |
|
59 |
59 |
$0.00 |
| 90744 |
|
110 |
107 |
$0.00 |
| 90696 |
|
25 |
25 |
$0.00 |
| 90633 |
|
51 |
49 |
$0.00 |
| 90700 |
|
15 |
15 |
$0.00 |
| 90710 |
|
26 |
25 |
$0.00 |